Extract
Cougar Biotechnology Reports First Quarter 2009 Financial Results.
LOS ANGELES -- Cougar Biotechnology, Inc. (NASDAQ: CGRB), a biotechnology company engaged in the in-license and development of clinical stage cancer drug candidates, today reported its financial results for the first quarter ended March 31, 2009.
First Quarter 2009 Financial Results For the quarter ended March 31, 2009, Couga...See the full content of this document
Sponsored links
